Regulus Therapeutics Inc (NASDAQ:RGLS)

16.82
Delayed Data
As of Mar 27
 +0.26 / +1.57%
Today’s Change
5.40
Today|||52-Week Range
25.60
+4.86%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Astrazeneca Plc
Sale11/12/20142,000,000$17.00$34.0M-14.27%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale3/05/201565,614$20.06$1.3M-20.40%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/28/201572,011$17.97$1.3M-4.76%
Gibson Neil W
Chief Scientific Officer
Sale1/28/201571,345$17.98$1.3M-4.76%
Alnylam Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K+22.33%
Isis Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K+22.33%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/29/201533,773$17.77$600.1K-9.47%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale3/05/201523,616$20.81$491.4K-20.40%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/29/201526,227$18.40$482.6K-9.47%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/28/201512,989$18.69$242.8K-4.76%
Page of 19

To view my watchlist

Not a member yet?

Sign up now for a free account